-+ 0.00%
-+ 0.00%
-+ 0.00%

Anaconda Biomed raises $56 million in funding round backed by Ysios Capital

PUBT·09/23/2026 18:42:05
Anaconda Biomed raises $56 million in funding round backed by Ysios Capital
  • Anaconda Biomed closed a USD 56 million private financing round to fund development of its stroke thrombectomy catheter portfolio.
  • Proceeds target completion of the ATHENA pivotal IDE study for the ANA Funnel Catheter, continued product development, regulatory approvals.
  • Omega Funds led the round; Ysios Capital Partners SGEIC SA participated alongside FOCO, Asabys, CDTI.
  • Anaconda develops funnel-based thrombectomy catheters designed to improve clot capture, limit embolic complications, increase brain reperfusion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ysios Capital Partners SGEIC SA published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.